SEC Form 4 · accession 0001869579-26-000007
Rani Therapeutics Holdings, Inc. · RANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Talat Imran
Officer — Chief Executive Officer · Director
Period of report
Jul 17, 2026
Accepted (ET)
Jul 21, 2026 · 6:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001856725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jul 17, 2026 | P | 35,000 | $0.7198 | A | 469,736 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.